Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2
The continuous emergence of SARS-CoV-2 variants caused the persistence of the COVID-19 epidemic and challenged the effectiveness of the existing vaccines. The viral proteases are the most attractive targets for developing antiviral drugs. In this scenario, our study explores the use of HIV-1 proteas...
Main Authors: | Davide Gentile, Lucia Chiummiento, Alessandro Santarsiere, Maria Funicello, Paolo Lupattelli, Antonio Rescifina, Assunta Venuti, Anna Piperno, Maria Teresa Sciortino, Rosamaria Pennisi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/16/3/338 |
Similar Items
-
Identification and Functional Analysis of a Pseudo-Cysteine Protease from the Midgut Transcriptome of <i>Sphenophorus levis</i>
by: Priscila Yumi Tanaka Shibao, et al.
Published: (2021-10-01) -
Roles of Cysteine Proteases in Biology and Pathogenesis of Parasites
by: Nawu Yang, et al.
Published: (2023-05-01) -
An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2
by: Rosamaria Pennisi, et al.
Published: (2023-12-01) -
Structure determinants defining the specificity of papain-like cysteine proteases
by: Anastasiia I. Petushkova, et al.
Published: (2022-01-01) -
The role of lysosomal cysteine proteases in crustacean immune response
by: FL Garcia-Carreño, et al.
Published: (2014-04-01)